Spyre Therapeutics (SYRE) Exchange Rate Effect (2020 - 2024)

Historic Exchange Rate Effect for Spyre Therapeutics (SYRE) over the last 5 years, with Q4 2024 value amounting to -$15000.0.

  • Spyre Therapeutics' Exchange Rate Effect fell 18333.33% to -$15000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$15000.0, marking a year-over-year decrease of 15000.0%. This contributed to the annual value of -$3000.0 for FY2024, which is 11200.0% down from last year.
  • Spyre Therapeutics' Exchange Rate Effect amounted to -$15000.0 in Q4 2024, which was down 18333.33% from $16000.0 recorded in Q3 2024.
  • Spyre Therapeutics' Exchange Rate Effect's 5-year high stood at $47000.0 during Q4 2020, with a 5-year trough of -$72000.0 in Q2 2022.
  • Moreover, its 5-year median value for Exchange Rate Effect was $3500.0 (2021), whereas its average is -$3250.0.
  • Examining YoY changes over the last 5 years, Spyre Therapeutics' Exchange Rate Effect showed a top increase of 143333.33% in 2022 and a maximum decrease of 190000.0% in 2022.
  • Spyre Therapeutics' Exchange Rate Effect (Quarter) stood at $47000.0 in 2020, then tumbled by 93.62% to $3000.0 in 2021, then skyrocketed by 1433.33% to $46000.0 in 2022, then tumbled by 60.87% to $18000.0 in 2023, then tumbled by 183.33% to -$15000.0 in 2024.
  • Its Exchange Rate Effect stands at -$15000.0 for Q4 2024, versus $16000.0 for Q3 2024 and -$4000.0 for Q1 2024.